Lantern Pharma Inc.

LTRN·NASDAQ·$3.38Share Price as of 11/2·$43MMarket Cap as of 11/2

Financials

10-QQ2 ended 06/30/2608/14/26 10-QQ1 ended 03/31/2605/15/26 10-K/AFY 202504/30/26 10-KFY 202503/30/26 10-QQ3 ended 09/30/2511/12/25

Disclosures

8-KDelisting or Transfer10/01/26 8-KCurrent report09/30/26 8-KRegulation FD Disclosure09/24/26 8-KRegulation FD Disclosure09/23/26 8-KCurrent report08/14/26

Prospectuses and Registrations

424B5Prospectus supplement09/30/26 S-1Registration statement (IPO)06/12/26 424B5Prospectus supplement05/14/26 424B5Prospectus supplement03/30/26 424B5Prospectus supplement07/03/25

Proxies

DEF 14ADefinitive proxy10/19/26 PRE 14APreliminary proxy10/08/26 DEF 14ADefinitive proxy08/08/25 PRE 14APreliminary proxy07/28/25 DEF 14ADefinitive proxy04/29/24

Ownership

SC 13G/ABeneficial ownership (amended)10/13/26 SC 13GBeneficial ownership08/04/26 SC 13G/ABeneficial ownership (amended)07/23/26 SC 13D/ABeneficial ownership (amended)05/15/26 Form 4Insider transaction05/14/26

Other

ARSAnnual report to shareholders10/21/26 EFFECTRequest for effectiveness06/18/26 DD05/21/26 ARSAnnual report to shareholders08/11/25 EFFECTRequest for effectiveness06/10/24